Effect of Unani drug on pain during menstruatio
Not Applicable
Completed
- Conditions
- Health Condition 1: N944- Primary dysmenorrhea
- Registration Number
- CTRI/2022/02/039988
- Lead Sponsor
- ational Institute of Unani Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Women aged from 18 to 35 years with a history of regular menstrual cycle (28 ±7 days) with primary dysmenorrhoea .6
Having experienced menstrual pain of intensity from moderate to severe and the Visual Analog Scale >¬4cm for at least three menstrual cycles before this study.6
Primary dysmenorrhoea with or without associated symptoms like headache, dizziness, fever, nausea, vomiting, diarrhoea and fatigue.
Exclusion Criteria
Patient with secondary dysmenorrhoea, heavy menstrual bleeding and irregular menstrual cycles.
Patient with malignancies.
Patient taking OCPs6 and using intrauterine devices.
Pregnant and lactating women.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Change in VAS Scale for pain intensityTimepoint: Once every month during treatment for three months
- Secondary Outcome Measures
Name Time Method Change in Health-related quality life assesses by SF12 Questionnaire and Change in uterine artery blood flow parameters (PI, RI and S/D ratio)Timepoint: At third month